Strengthening European resilience in the manufacturing and supply of medicines
The COVID-19 crisis has brought many long-standing questions about pandemic response to the fore across all sectors. For the pharmaceutical
Read moreThe COVID-19 crisis has brought many long-standing questions about pandemic response to the fore across all sectors. For the pharmaceutical
Read moreWhere we stand today Since the outbreak of Covid-19, Europe has been operating in a crisis mode. In order to
Read moreECSEL JU (www.ecsel.eu) operates a unique model for financing collaborative RD&I in Europe, which brings together the best of Industry,
Read moreFor years, one of the main challenges of the Union was to stimulate economic growth while ensuring global competitiveness. In
Read moreThe sanitary crisis with the disruption of goods and services flows reminded Europe of the vulnerabilities in its economic model,
Read moreToday, Europe finds itself at an important point in time. The geopolitical changes in recent years have led to shifting
Read moreThere are a number of reasons to be optimistic about the Resolution on medicine shortages adopted by the European Parliament
Read moreShortages of masks, hydroalcoholic gel, reagents for screening tests, respiratory assistance equipment and anaesthetics in intensive care units… The COVID-19
Read more